Fintel reports that on April 17, 2025, BMO Capital downgraded their outlook for Novo Nordisk A (NYSE:NVO) from Outperform to ...

The sell-America trade gathered momentum on Monday on concern President Donald Trump will act upon his threat of firing ...

BMO Capital downgraded Novo Nordisk (NVO) to Market Perform from Outperform with a price target of $64, down from $105. The company’s obesity ...

BMO Capital analyst Ketan Mamtora upgraded Trex Company (TREX) to Outperform from Market Perform with an unchanged price target of $72. The ...

While many on Wall Street are cutting their year-end price targets after Trump's tariff announcement, one strategist is still ...

Google illegally acted to preserve “monopoly power” in the ad-tech business, a federal judge ruled Thursday. It’s the second ...

NEW YORK, April 9 (Reuters) - BMO Capital on Wednesday cut its year-end 2025 S&P 500 (.SPX), opens new tab target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent ...

Investing.com -- BMO Capital Markets upgraded Check Point Software Technologies (NASDAQ:CHKP) Ltd to Outperform from Market Perform, citing increased confidence in the company’s growth ...

Brokers say that homeowners with the ability to handle the risk associated with a variable mortgage could benefit in the ...

Metro (TSE:MRU – Free Report) had its price objective upped by BMO Capital Markets from C$96.00 to C$110.00 in a research note issued to investors on Friday,BayStreet.CA reports. MRU has been the ...